Drug Shortage Report for M-PRAVASTATIN
Report ID | 108898 |
Drug Identification Number | 02476282 |
Brand name | M-PRAVASTATIN |
Common or Proper name | Pravastatin |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PRAVASTATIN SODIUM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-02-11 |
Estimated end date | 2020-04-10 |
Actual end date | 2020-04-15 |
Shortage status | Resolved |
Updated date | 2020-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-18 | English | Compare |
v2 | 2020-03-18 | French | Compare |
v3 | 2020-04-15 | English | Compare |
v4 | 2020-04-15 | English | Compare |
v5 | 2020-04-16 | English | Compare |
Showing 1 to 5 of 5